Valuation: Haleon plc

Market Cap 32.56B 44.39B 38.04B 35.64B 61.44B 4,232B 62.05B 420B 164B 2,135B 167B 163B 7,071B P/E 2026 *
19.2x
P/E 2027 * 17x
Enterprise Value 39.43B 53.76B 46.07B 43.17B 74.42B 5,126B 75.15B 509B 198B 2,586B 202B 197B 8,564B EV / Sales 2026 *
3.46x
EV / Sales 2027 * 3.27x
Free-Float
98.46%
Yield 2026 *
2.19%
Yield 2027 * 2.42%
1 day-0.05%
1 week+3.94%
Current month+1.73%
1 month+1.68%
3 months+7.50%
6 months-2.20%
Current year-1.39%
1 week 355.8
Extreme 355.8
370.6
1 month 348.8
Extreme 348.8
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%+3.94%+1.40%+12.77% 44.44B
-1.06%+0.65%+77.42%+122.82% 1,111B
+0.53%+0.75%+53.10%+64.29% 658B
+0.48%+2.65%+28.06%+81.19% 467B
+0.92%+3.57%+43.82%+44.21% 369B
+1.25%+2.21%+26.77%+43.05% 301B
+3.02%+5.68%+4.24%+17.04% 256B
-0.36%+3.99%+53.31%+72.49% 240B
+2.86%+3.86%-16.20%-51.83% 207B
+1.38%+3.72%+30.33%+93.56% 182B
Average +0.90%+3.05%+30.22%+49.96% 383.55B
Weighted average by Cap. +0.43%+2.22%+45.48%+71.61%

Financials

2026 *2027 *
Net sales 11.39B 15.53B 13.31B 12.47B 21.5B 1,481B 21.71B 147B 57.27B 747B 58.32B 57.05B 2,474B 11.87B 16.19B 13.87B 13B 22.4B 1,543B 22.62B 153B 59.68B 779B 60.77B 59.45B 2,578B
Net income 1.7B 2.31B 1.98B 1.86B 3.2B 221B 3.23B 21.91B 8.53B 111B 8.69B 8.5B 369B 1.92B 2.62B 2.24B 2.1B 3.62B 250B 3.66B 24.8B 9.66B 126B 9.83B 9.62B 417B
Net Debt 6.87B 9.37B 8.03B 7.53B 12.97B 894B 13.1B 88.77B 34.56B 451B 35.19B 34.43B 1,493B 6.26B 8.54B 7.32B 6.86B 11.82B 814B 11.94B 80.89B 31.49B 411B 32.07B 31.37B 1,360B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-08-25 GBX 369.60 -0.05% 20,004,843
26-08-24 GBX 369.80 +1.85% 19,864,563
26-08-21 GBX 363.10 +0.89% 14,337,114
26-08-20 GBX 359.90 +0.56% 20,882,955
26-08-19 GBX 357.90 +0.65% 23,666,803
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.696GBP
Average target price
4.214GBP
Spread / Average Target
+14.02%

Quarterly revenue - Rate of surprise